Related Experiment Video
Updated: Aug 10, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Relapses and remissions in brain stem tumours
Brain stem astrocytoma and vascular tumors can present with relapsing symptoms. Necropsy confirmed diagnoses, suggesting edema and necrosis contribute to the fluctuating clinical course in these brain lesions.
Area of Science:
- Neurology
- Oncology
- Pathology
Background:
- Brain stem tumors, including astrocytoma and vascular tumors, can exhibit complex clinical presentations.
- Relapsing and remitting symptoms in brain stem lesions pose diagnostic challenges.
Purpose of the Study:
- To describe cases of brain stem tumors with a relapsing-remitting course.
- To investigate potential pathological mechanisms underlying fluctuating tumor behavior.
- To emphasize the importance of thorough neuroradiological evaluation for recurrent brain stem lesions.
Main Methods:
- Case series presentation of three brain stem astrocytomas and one para-stem vascular tumor.
- Necropsy confirmation of diagnoses.
- Clinical history review focusing on disease course and symptoms.
Main Results:
- All described tumors exhibited a history of relapses and remissions.
- Edema and necrosis in both tumor and surrounding brain tissue were suggested as causes for the relapsing course.
- Recurrent lesions at the same brain stem site were observed.
Conclusions:
- The fluctuating clinical course of brain stem tumors may be attributed to edema and necrosis.
- Repeated recurrence in the brain stem warrants comprehensive neuroradiological investigation.
- Differential diagnosis of brain stem lesions should consider tumor recurrence over conditions like multiple sclerosis.
More Related Videos
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
07:42Modelling Brain Metastasis: Standardized Analysis of Metastatic Colonization and Histological Growth Patterns by Stereotactic Intracortical Injection
Published on: January 16, 2026